Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Gynecology

Free Subscription Articles published in Cancer Retrieve available abstracts of 53 articles: HTML format Text format

Single Articles

May 2019
1. PRINTZ C
   Cervical cancer self-sampling tests could improve access.
   Cancer. 2019;125:1583.
   PubMed     Text format    
   
   
   
2. PINSKY PF, Black A, Daugherty SE, Hoover R, et al
   Metastatic prostate cancer at diagnosis and through progression in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
   Cancer. 2019 May 8. doi: 10.1002/cncr.32176.
   PubMed     Text format     Abstract available
   
   
   March 2019
3. KURNIT KC, Westin SN, Coleman RL
   Microsatellite instability in endometrial cancer: New purpose for an old test.
   Cancer. 2019 Mar 26. doi: 10.1002/cncr.32058.
   PubMed     Text format    
   
   
   
4. BAST RC JR, Matulonis UA, Sood AK, Ahmed AA, et al
   Critical Questions in Ovarian Cancer Research and Treatment: Report of an American Association for Cancer Research Special Conference.
   Cancer. 2019 Mar 5. doi: 10.1002/cncr.32004.
   PubMed     Text format     Abstract available
   
   
   February 2019
5. GROVER S, MacDuffie EC, Wang Q, Bvochora-Nsingo M, et al
   HIV infection is not associated with the initiation of curative treatment in women with cervical cancer in Botswana.
   Cancer. 2019 Feb 25. doi: 10.1002/cncr.31972.
   PubMed     Text format     Abstract available
   
   
   January 2019
6. MAO W, Peters HL, Sutton MN, Orozco AF, et al
   The role of vascular endothelial growth factor, interleukin 8, and insulinlike growth factor in sustaining autophagic DIRAS3-induced dormant ovarian cancer xenografts.
   Cancer. 2019 Jan 8. doi: 10.1002/cncr.31935.
   PubMed     Text format     Abstract available
   
   
   December 2018
7. TEMKIN SM, Mallen A, Bellavance E, Rubinsak L, et al
   The role of menopausal hormone therapy in women with or at risk of ovarian and breast cancers: Misconceptions and current directions.
   Cancer. 2018 Dec 20. doi: 10.1002/cncr.31911.
   PubMed     Text format     Abstract available
   
   
   
8. ESKANDER RN
   Mismatch repair in endometrioid endometrial cancer: Increasing our therapeutic proficiency by capitalizing on molecular deficiency.
   Cancer. 2018 Dec 18. doi: 10.1002/cncr.31902.
   PubMed     Text format    
   
   
   
9. BACKES FJ, Haag J, Cosgrove CM, Suarez A, et al
   Mismatch repair deficiency identifies patients with high-intermediate-risk (HIR) endometrioid endometrial cancer at the highest risk of recurrence: A prognostic biomarker.
   Cancer. 2018 Dec 18. doi: 10.1002/cncr.31901.
   PubMed     Text format     Abstract available
   
   
   
10. PRINTZ C
    High-risk human papillomavirus test a good option for cervical cancer screening.
    Cancer. 2018;124:4591.
    PubMed     Text format    
    
    
    
11. PRINTZ C
    Human papillomavirus testing may detect cervical precancer better than Papanicolaou testing.
    Cancer. 2018;124:4430-4431.
    PubMed     Text format    
    
    
    November 2018
12. BINES J, Tevaarwerk AJ
    Baby steps: Pregnancy outcomes after human epidermal growth factor receptor 2-targeted therapy.
    Cancer. 2018 Nov 30. doi: 10.1002/cncr.31878.
    PubMed     Text format    
    
    
    
13. LAITMAN Y, Michaelson-Cohen R, Levi E, Chen-Shtoyerman R, et al
    Uterine cancer in Jewish Israeli BRCA1/BRCA2 mutation carriers.
    Cancer. 2018 Nov 29. doi: 10.1002/cncr.31842.
    PubMed     Text format     Abstract available
    
    
    
14. FREY MK, Kopparam RV, Ni Zhou Z, Fields JC, et al
    Prevalence of nonfounder BRCA1/2 mutations in Ashkenazi Jewish patients presenting for genetic testing at a hereditary breast and ovarian cancer center.
    Cancer. 2018 Nov 27. doi: 10.1002/cncr.31856.
    PubMed     Text format     Abstract available
    
    
    
15. AHVENAINEN TV, Makinen NM, von Nandelstadh P, Vahteristo MEA, et al
    Loss of ATRX/DAXX expression and alternative lengthening of telomeres in uterine leiomyomas.
    Cancer. 2018 Nov 13. doi: 10.1002/cncr.31754.
    PubMed     Text format     Abstract available
    
    
    
16. SMITH HJ, McCaw TR, Londono AI, Katre AA, et al
    The antitumor effects of entinostat in ovarian cancer require adaptive immunity.
    Cancer. 2018 Nov 13. doi: 10.1002/cncr.31761.
    PubMed     Text format     Abstract available
    
    
    
17. HARTNETT KP, Mertens AC, Kramer MR, Lash TL, et al
    Pregnancy after cancer: Does timing of conception affect infant health?
    Cancer. 2018 Nov 7. doi: 10.1002/cncr.31732.
    PubMed     Text format     Abstract available
    
    
    
18. PARTRIDGE AH
    Pregnancy after cancer: Timing is everything.
    Cancer. 2018 Nov 7. doi: 10.1002/cncr.31730.
    PubMed     Text format    
    
    
    
19. MAILHOT VEGA RB, Balogun OD, Ishaq OF, Bray F, et al
    Estimating child mortality associated with maternal mortality from breast and cervical cancer.
    Cancer. 2018 Nov 1. doi: 10.1002/cncr.31780.
    PubMed     Text format     Abstract available
    
    
    October 2018
20. LAMBERTINI M, Martel S, Campbell C, Guillaume S, et al
    Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2-positive early breast cancer: analysis from the NeoALTTO (BIG 1-06) and ALTTO (BIG 2-06) trials.
    Cancer. 2018 Oct 18. doi: 10.1002/cncr.31784.
    PubMed     Text format     Abstract available
    
    
    
21. CHLEBOWSKI RT, Luo J, Anderson GL, Barrington W, et al
    Weight loss and breast cancer incidence in postmenopausal women.
    Cancer. 2018 Oct 8. doi: 10.1002/cncr.31687.
    PubMed     Text format     Abstract available
    
    
    September 2018
22. 
    Survivors of endometrial cancer are more likely to experience cardiovascular problems.
    Cancer. 2018;124:3633.
    PubMed     Text format    
    
    
    June 2018
23. ARMER JS, Clevenger L, Davis LZ, Cuneo M, et al
    Life stress as a risk factor for sustained anxiety and cortisol dysregulation during the first year of survivorship in ovarian cancer.
    Cancer. 2018 Jun 15. doi: 10.1002/cncr.31570.
    PubMed     Text format     Abstract available
    
    
    May 2018
24. DUSKA LR
    Access to quality gynecologic oncology care: A work in progress.
    Cancer. 2018 May 16. doi: 10.1002/cncr.31391.
    PubMed     Text format    
    
    
    
25. SHALOWITZ DI, Huh WK
    Access to gynecologic oncology care and the network adequacy standard.
    Cancer. 2018 May 16. doi: 10.1002/cncr.31392.
    PubMed     Text format    
    
    
    
26. ADAR T, Rodgers LH, Shannon KM, Yoshida M, et al
    Universal screening of both endometrial and colon cancers increases the detection of Lynch syndrome.
    Cancer. 2018 May 11. doi: 10.1002/cncr.31534.
    PubMed     Text format     Abstract available
    
    
    March 2018
27. 
    Erratum: Pashankar F, Hale JP, Dang H, et al. Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the Malignant Germ Cell Tumor International Collaborative. Cancer. 2016;122:230-237.
    Cancer. 2018;124:1302.
    PubMed     Text format    
    
    
    February 2018
28. IYER NS, Cartmel B, Friedman L, Li F, et al
    Lymphedema in ovarian cancer survivors: Assessing diagnostic methods and the effects of physical activity.
    Cancer. 2018 Feb 13. doi: 10.1002/cncr.31239.
    PubMed     Text format     Abstract available
    
    
    
29. PRINTZ C
    Abdominal fat linked to cancer risk in postmenopausal women.
    Cancer. 2018;124:449.
    PubMed     Text format    
    
    
    January 2018
30. LEVINE JM, Whitton JA, Ginsberg JP, Green DM, et al
    Nonsurgical premature menopause and reproductive implications in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study.
    Cancer. 2018 Jan 16. doi: 10.1002/cncr.31121.
    PubMed     Text format     Abstract available
    
    
    
31. RAZZAGHI H, Saraiya M, Thompson TD, Henley SJ, et al
    Five-year relative survival for human papillomavirus-associated cancer sites.
    Cancer. 2018;124:203-211.
    PubMed     Text format     Abstract available
    
    
    December 2017
32. STEWART SL, Harewood R, Matz M, Rim SH, et al
    Disparities in ovarian cancer survival in the United States (2001-2009): Findings from the CONCORD-2 study.
    Cancer. 2017;123 Suppl 24:5138-5159.
    PubMed     Text format     Abstract available
    
    
    
33. BENARD VB, Watson M, Saraiya M, Harewood R, et al
    Cervical cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.
    Cancer. 2017;123 Suppl 24:5119-5137.
    PubMed     Text format     Abstract available
    
    
    
34. TAARNHOJ GA, Christensen IJ, Lajer H, Fuglsang K, et al
    Risk of recurrence, prognosis, and follow-up for Danish women with cervical cancer in 2005-2013: A national cohort study.
    Cancer. 2017 Dec 6. doi: 10.1002/cncr.31165.
    PubMed     Text format     Abstract available
    
    
    
35. GROEN R, Abe K, Yoon HS, Li Z, et al
    Application of microscope-based scanning software (Panoptiq) for the interpretation of cervicovaginal cytology specimens.
    Cancer. 2017;125:918-925.
    PubMed     Text format     Abstract available
    
    
    November 2017
36. PRINTZ C
    Large population study quantifies chances of pregnancy after cancer treatment.
    Cancer. 2017;123:4308.
    PubMed     Text format    
    
    
    
37. LUTGENDORF SK, Thaker PH, Arevalo JM, Goodheart MJ, et al
    Biobehavioral modulation of the exosome transcriptome in ovarian carcinoma.
    Cancer. 2017 Nov 7. doi: 10.1002/cncr.31078.
    PubMed     Text format     Abstract available
    
    
    October 2017
38. CHAD-FRIEDMAN E, Coleman S, Traeger LN, Pirl WF, et al
    Psychological distress associated with cancer screening: A systematic review.
    Cancer. 2017;123:3882-3894.
    PubMed     Text format     Abstract available
    
    
    
39. NELSON RA, Lai LL
    Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
    Cancer. 2017;123:4013-4021.
    PubMed     Text format     Abstract available
    
    
    September 2017
40. LE GALLO M, Rudd ML, Urick ME, Hansen NF, et al
    The FOXA2 transcription factor is frequently somatically mutated in uterine carcinosarcomas and carcinomas.
    Cancer. 2017 Sep 21. doi: 10.1002/cncr.30971.
    PubMed     Text format     Abstract available
    
    
    
41. PRINJA S, Bahuguna P, Faujdar DS, Jyani G, et al
    Cost-effectiveness of human papillomavirus vaccination for adolescent girls in Punjab state: Implications for India's universal immunization program.
    Cancer. 2017;123:3253-3260.
    PubMed     Text format     Abstract available
    
    
    August 2017
42. TRACHT JM, Davis AD, Fasciano DN, Eltoum IA, et al
    Discrepant HPV/cytology cotesting results: Are there differences between cytology-negative versus HPV-negative cervical intraepithelial neoplasia?
    Cancer. 2017 Aug 17. doi: 10.1002/cncy.21905.
    PubMed     Text format     Abstract available
    
    
    
43. MOORE KN, Borghaei H, O'Malley DM, Jeong W, et al
    Phase 1 dose-escalation study of mirvetuximab soravtansine (IMGN853), a folate receptor alpha-targeting antibody-drug conjugate, in patients with solid tumors.
    Cancer. 2017;123:3080-3087.
    PubMed     Text format     Abstract available
    
    
    
44. HUNG YP, Lovitch SB, Qian X
    Histiocytic sarcoma: New insights into FNA cytomorphology and molecular characteristics.
    Cancer. 2017;125:604-614.
    PubMed     Text format     Abstract available
    
    
    July 2017
45. PRINTZ C
    Expert panel issues new global cervical cancer screening guideline.
    Cancer. 2017;123:2387-2388.
    PubMed     Text format    
    
    
    June 2017
46. GE Y, Christensen P, Luna E, Armylagos D, et al
    Performance of Aptima and Cobas HPV testing platforms in detecting high-grade cervical dysplasia and cancer.
    Cancer. 2017 Jun 2. doi: 10.1002/cncy.21875.
    PubMed     Text format     Abstract available
    
    
    May 2017
47. GUO M, Khanna A, Wang J, Dawlett MA, et al
    Three-year risk of high-grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co-screening.
    Cancer. 2017 May 12. doi: 10.1002/cncy.21877.
    PubMed     Text format     Abstract available
    
    
    
48. IVY SP, Kohn EC
    Drug development and registration: Challenges and opportunities in ovarian cancer.
    Cancer. 2017 May 12. doi: 10.1002/cncr.30645.
    PubMed     Text format    
    
    
    March 2017
49. SAMIMI G, Minasian LM
    Opportunistic salpingectomy: What about the role of the ovary in ovarian cancer?
    Cancer. 2017 Mar 23. doi: 10.1002/cncr.30525.
    PubMed     Text format    
    
    
    February 2017
50. ZANET E, Ciancia R, Michieli M, Tirelli U, et al
    "Twistin' the night away": Fertility preservation in young adult female cancer survivors.
    Cancer. 2017;123:707-708.
    PubMed     Text format    
    
    
    
51. BENEDICT C, Thom B, Friedman DN, Diotallevi D, et al
    Reply to "Twistin' the night away": Fertility preservation in young adult female cancer survivors.
    Cancer. 2017;123:708-709.
    PubMed     Text format    
    
    
    
52. JACKSON SE, Steptoe A, Fisher A
    Reply to Sexual quality of life in the cancer continuum.
    Cancer. 2017;123:530-531.
    PubMed     Text format    
    
    
    December 2016
53. GULATI R, Albertsen PC
    Insights from the PLCO trial about prostate cancer screening.
    Cancer. 2016 Dec 1. doi: 10.1002/cncr.30472.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: